<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> is a major characteristic of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and is causally associated with <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> plays an important role in <z:hpo ids='HP_0001513'>obesity</z:hpo>-associated <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, but the underlying mechanism remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>Interleukin (IL)-10 is an anti-inflammatory cytokine with lower circulating levels in <z:mp ids='MP_0001261'>obese</z:mp> subjects, and <z:hpo ids='HP_0011009'>acute</z:hpo> treatment with IL-10 prevents <z:chebi fb="23" ids="18059">lipid</z:chebi>-induced <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We examined the role of IL-10 in <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis using transgenic mice with muscle-specific overexpression of IL-10 (MCK-IL10) </plain></SENT>
<SENT sid="4" pm="."><plain>RESEARCH DESIGN AND METHODS: MCK-IL10 and <z:mp ids='MP_0002169'>wild-type</z:mp> mice were fed a high-fat diet (HFD) for 3 weeks, and insulin sensitivity was determined using hyperinsulinemic-euglycemic clamps in conscious mice </plain></SENT>
<SENT sid="5" pm="."><plain>Biochemical and molecular analyses were performed in muscle to assess <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, insulin signaling, and <z:mp ids='MP_0001845'>inflammatory responses</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: MCK-IL10 mice developed with no obvious anomaly and showed increased whole-body insulin sensitivity </plain></SENT>
<SENT sid="7" pm="."><plain>After 3 weeks of HFD, MCK-IL10 mice developed comparable <z:hpo ids='HP_0001513'>obesity</z:hpo> to <z:mp ids='MP_0002169'>wild-type</z:mp> littermates but remained insulin sensitive in skeletal muscle </plain></SENT>
<SENT sid="8" pm="."><plain>This was mostly due to significant increases in <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, insulin receptor substrate-1, and Akt activity in muscle </plain></SENT>
<SENT sid="9" pm="."><plain>HFD increased macrophage-specific CD68 and F4/80 levels in <z:mp ids='MP_0002169'>wild-type</z:mp> muscle that was associated with marked increases in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha, IL-6, and C-C motif chemokine receptor-2 levels </plain></SENT>
<SENT sid="10" pm="."><plain>In contrast, MCK-IL10 mice were protected from diet-induced <z:mp ids='MP_0001845'>inflammatory response</z:mp> in muscle </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: These results demonstrate that IL-10 increases insulin sensitivity and protects skeletal muscle from <z:hpo ids='HP_0001513'>obesity</z:hpo>-associated macrophage infiltration, increases in inflammatory cytokines, and their deleterious effects on insulin signaling and <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism </plain></SENT>
<SENT sid="12" pm="."><plain>Our findings provide novel insights into the role of anti-inflammatory cytokine in the treatment of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>